The ‘ecology of strains’ is imperative to consider in the research of the infant microbiome, as not all Bifidobacterium strains work equally, Dr. Bernard Berger, R&D expert microbiome and probiotics at Nestlé Research told NutraIngredients.
The ingredients division of the Dutch dairy co-op said its 2’-fucosyllactose ingredient has been approved for use in both infant formulas as well as young children products.
Food Standards Australia New Zealand (FSANZ) has approved dsm-firmenich’s four human milk oligosaccharides (HMOs), including the mixture of 2’-fucosyllactose (2’-FL) and difucosyllactose (DFL), for use in infant formula products.
Exposure to an infant formula mimicking human milk lipid composition and milk fat globule structure positively affects child neurocognitive development, a new randomised, controlled trial has concluded.
Chr. Hansen has received regulatory approval to supply a range of Human Milk Oligosaccharides (HMO) to new and existing global markets, following recent endorsements from Australia and New Zealand last year.
Levels of two specific human milk oligosaccharides (HMOs) are linked with measure of infant cognitive development, says a pilot study led by R&D Abbott Nutrition.
Existing research on human milk oligosaccharides (HMOs) is only at the tip of the iceberg and there are vast opportunities for developing new pre/probiotics/synbiotics with HMOs, says an expert specialising in this field.
The potential health effects of human milk oligosaccharides (HMOs) for adults may extend beyond just promoting the growth of beneficial Bifidobacteria to also impacting immune function and the gut barrier, says a new study.